HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M C L Fernando Selected Research

Neutropenia

9/2015First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M C L Fernando Research Topics

Disease

1Anemia
09/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015
1Exanthema (Rash)
09/2015
1Leukopenia
09/2015
1Neutropenia
09/2015

Drug/Important Bio-Agent (IBA)

1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2015
1GemcitabineFDA Link
09/2015
1Cisplatin (Platino)FDA LinkGeneric
09/2015
1ErbB Receptors (EGF Receptor)IBA
09/2015